TOP TIERMARKET NEWSWIRE
News & sentiment

THERAVANCE BIOPHARMA (TBPH) — News & AI sentiment

THERAVANCE BIOPHARMA (TBPH) news roundup. 2 stories in the past week, 5 over 30 days. Average 30-day sentiment is 48.4/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 3 sales totalling $6.1M — net selling of $6.1M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 44/100
30d stories
5
avg sentiment 48.4/100
Insider net (90d)
$6.1M
0 buys · 3 sells
Congress (90d)
0
0 buys · 0 sells

TBPH news in the last 24 hours, 7 days, 30 days and 90 days

How much TBPH coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowTBPH storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days244/100TBPH headlines →
Last 30 days548.4/100TBPH headlines →
Last 90 days2753.9/100TBPH headlines →

Latest stories on TBPH

3d ago
3d ago
Aug 25
Aug 25
Aug 15
Aug 10
Aug 10
Aug 10
A Post Acquisition Look At Zymeworks
Seeking Alpha63 · neutralm&a
Aug 5
Jul 9
Jul 1
Jun 30
Jun 29
Jun 29
Jun 29
Jun 29
Jun 29
Jun 29
Jun 29
Jun 29
Jun 29
Jun 29
Jun 29
Jun 29
Jun 29
Open TBPH in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →